Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.22.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense
             
    2022     2021  
             
Expected federal income tax benefit at statutory rate   $ 7,184,840     $ 8,426,269  
Non-deductible expenses     (288,249 )     (224,189 )
Research and development credit     595,244       537,705  
Return to provision true up     93,285       (94,707 )
Change in valuation allowance     (7,585,120 )     (8,834,492 )
Income tax benefit   $     $  
Schedule of deferred tax assets and liabilities
             
    2022     2021  
Deferred tax assets                
Net operating losses   $ 9,106,430     $ 5,078,075  
Depreciation and amortization     1,502,868       46,030  
Research & development credit     1,308,956       592,276  
Lease liability     322,167       466,980  
Stock-based compensation     3,103,037       2,872,973  
Inventory     1,290,968        
Accrued expenses     233,284       478,171  
Capital loss carryover     261,922        
Other     177,074       336  
Total     17,306,705       9,534,840  
Valuation allowance     (16,661,612 )     (9,076,492 )
Net deferred tax asset     645,093       458,348  
Deferred tax liabilities                
Prepaid expenses     (328,836 )      
Right-of-use assets     (316,257 )     (458,348 )
Total net deferred taxes Deferred tax liabilities   $     $